Ecolab (ECL) Q1 2026 earnings snapshot

Ecolab (ECL) opened 2026 with Q1 revenue of US$4.1 billion and basic EPS of US$1.53, alongside trailing twelve month revenue of US$16.5 billion and EPS of US$7.44 that frame how the latest quarter fits into the broader run rate. Over the past year, the company has seen quarterly revenue move from US$3,695 million in Q1 2025 to US$4,066.1 million in Q1 2026, while basic EPS over that same period shifted from US$1.42 to US$1.53, giving investors a clear view of how the top and bottom line are tracking into the new financial year. With trailing net margin sitting just below last year’s level and earnings growth forecasts near 11.5% a year, the story now turns to how resilient those margins look as the year unfolds.

See our full analysis for Ecolab.

With the latest results on the table, the next step is to see how these numbers line up with the dominant market narratives around Ecolab’s growth, profitability, and risk profile.

Margins ease from 13.4% to 12.9%

• Trailing net profit margin sits at 12.9%, a touch below the 13.4% level reported a year earlier, while trailing twelve month net income is US$2.1b on revenue of US$16.5b.
• Consensus narrative points to the One Ecolab initiative and pricing actions as long term margin drivers. However, the small step down in margin and Q1 2026 net income of US$432.6 million versus US$563.9 million in Q4 2025 shows that, even with value pricing and digital investments, softer demand and higher input costs are still visible in the reported numbers.
  • The focus on value pricing and a 190 basis point operating income margin improvement cited in the consensus view sits alongside trailing margins that are slightly lower year on year, which keeps the bullish case on margins in check.
  • Life Sciences and digital are described as high margin growth engines in the consensus view, but with revenue growing about 6.2% a year and margin at 12.9%, the impact of these areas is not yet overwhelming the pressure from tariffs and local supplier costs.

Earnings forecasts outpace 6.2% revenue growth

• Over the last year, revenue grew about 6.2% annually, while earnings are forecast to grow around 11.5% a year, and trailing twelve month EPS stands at US$7.44.
• Supporters of the bullish narrative highlight expected EPS of US$10.77 by about 2029 and margin expansion to 15%. The current gap between 6.2% revenue growth and the 11.5% earnings growth forecast means a lot of that optimism rests on further efficiency gains and mix shift rather than a clear acceleration in reported top line today.
  • Trailing twelve month net income of US$2.1b compared with the forecast US$3.0b level cited in the narrative shows there is still meaningful ground to cover for the bullish case to fully play out.
  • Analysts also expect shares outstanding to edge down by 0.54% a year, so part of the path from US$7.44 EPS today to US$10.77 relies on financial structuring as well as the operating improvements that the One Ecolab initiative is aiming for.

On these numbers, bulls are effectively betting that future margin gains and mix improvements can do more work than the recent 6.2% revenue growth alone suggests, and that is exactly the tension unpacked in the 🐂 Ecolab Bull Case

Rich 36.3x P/E and DCF gap

• The shares trade on a trailing P/E of 36.3x, above the US Chemicals industry at 31.6x and peers at 29.9x, and the current share price of US$266.96 sits above a DCF fair value estimate of US$246.74.
• Critics of the stock argue that paying a higher multiple than both industry and peers plus a premium to DCF fair value is hard to square with only 6.2% revenue growth and a net margin of 12.9% that is slightly below last year, especially with a high level of debt flagged as a risk.
  • The analyst price target of US$318.48 is about 19.3% above the current US$266.96 price, so the market is already giving some credit to the earnings growth outlook even though valuation screens as expensive versus the DCF fair value of US$246.74.
  • The combination of a 36.3x P/E, a share price above DCF fair value, and high debt means bears have concrete numbers to point to when they question how much more room there is for the multiple if the margin profile does not move far above the current 12.9% level.

Skeptics watching the 36.3x P/E, premium to the US$246.74 DCF fair value, and high debt levels may want a closer look at the cautious case before deciding how comfortable they are with the current price tag 🐻 Ecolab Bear Case

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Ecolab on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

With bulls and bears both armed with data points on growth, margins, valuation and balance sheet, this is a good moment to review the full picture yourself and move quickly from headlines to your own view by weighing the 1 key reward and 1 important warning sign.

Explore Alternatives

Ecolab combines a rich 36.3x P/E and a share price above a DCF fair value estimate with only 6.2% revenue growth and slightly softer margins.

If that combination of premium pricing, modest growth, and balance sheet concerns makes you cautious, use the 72 resilient stocks with low risk scores to quickly spot companies with steadier profiles and potentially more comfortable risk levels.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.